Doctors May Have Moved Closer to Blood Test to Predict Alzheimer’s Risk
Early intervention in the treatment of dementia and Alzheimer’s is one of the challenges medical professionals face. But scientists may be one step closer in predicting those at risk.
A team from Georgetown University School of Medicine developed a blood test which measures the level of lipids to predict risk of Alzheimer’s disease and similar conditions. Lipids may decline during the breakdown of brain cell membranes upon the onset of Alzheimer’s.
Researchers analyzed lipid levels in blood samples from 525 volunteers who were all over 70 years old. With 90 percent accuracy, they were able to predict if the patient would develop Alzheimer’s or mild cognitive impairment (MCI) within three years.
This could be a significant step in the right direction to help determine the likelihood of developing what can become a debilitating disease. By identifying those at risk, treatment could start earlier.
Although the focus of the blood test is on the elderly, Alzheimer’s is a condition that can strike those still in their working years. The Alzheimer’s Association estimates that more than 200,000 people in the United States suffer from what’s known as early-onset Alzheimer’s.
It typically strikes people in their 40s and 50s and it can completely devastate the individual and the family—not only because of the physical and emotional repercussions but financially when the person’s symptoms have progressed to a point that working is no longer an option.
Those facing early-onset Alzheimer’s may be eligible to collect Social Security disability benefits. In fact, the process of acquiring these benefits could be accelerated because this condition falls under Social Security Administration’s (SSA) Compassionate Allowances program. To learn if you or someone you love qualifies for disability benefits, speak with Disability Help Group. Call us at 1-(800)-800-3332.